Roche Registration GmbH
- J05 - Antivirales de uso sistémico
- TAMIFLU capsule, hard 30 mg
- TAMIFLU capsule, hard 45 mg
- TAMIFLU capsule, hard 75 mg
- TAMIFLU powder for oral suspension 12 mg/ml
- XOFLUZA film-coated tablet 20 mg
- XOFLUZA film-coated tablet 40 mg
- L01 - Antineoplásicos
- ROZLYTREK capsule, hard 100 mg
- ROZLYTREK capsule, hard 200 mg
- TARCEVA film-coated tablet 100 mg
- TARCEVA film-coated tablet 150 mg
- TARCEVA film-coated tablet 25 mg
- TECENTRIQ concentrate for solution for infusion 1 200 mg/20 ml
- TECENTRIQ concentrate for solution for infusion 840 mg/14 ml
- ZELBORAF film-coated tablet 240 mg
- L04 - Inmunosupresores
- ROACTEMRA concentrate for solution for infusion 20 mg/ml
- ROACTEMRA PREFILLED SYRINGE solution for injection 162 mg